Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions

NCT01222923 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Risperidone

Sponsor

Ranbaxy Laboratories Limited